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Abstract
Abdominal surgery performed in patients with significant liver disease and portal hypertension is associated with high mor-
tality rates, with even poorer outcomes associated with complex pancreaticobiliary operations. We report on a patient
requiring portal decompression via transjugular intrahepatic portosystemic shunt (TIPS) prior to a pancreaticoduodenect-
omy. The 49-year-old patient presented with pain, jaundice and weight loss. At ERCP an edematous ampulla was biopsied,
revealing high-grade dysplasia within a distal bile duct adenoma. Liver biopsy was performed to investigate portal hyperten-
sion, confirming congenital hepatic fibrosis (CHF). A TIPS was performed to enable a pancreaticoduodenectomy. Prophylactic
TIPS can be performed for preoperative portal decompression for patients requiring pancreatic resection. A potentially cura-
tive resection was performed when abdominal surgery was initially thought impossible. Notably, CHF has been associated
with the development of cholangiocarcinoma in only four previous instances, with this case being only the second reported
distal bile duct cholangiocarcinoma.
INTRODUCTION
General surgery procedures in patients with significant liver
disease, cirrhosis and concomitant portal hypertension are
associated with high mortality rates [1]. Recently, minimally
invasive transjugular intrahepatic portosystemic shunt (TIPS)
procedures have replaced surgical portosystemic shunts. This
technique is capable of reducing portal hypertension-
associated complications leading to reduced intraoperative
bleeding and perioperative complications in patients undergo-
ing major extrahepatic surgery, but experience remains limited
[1]. Pancreatic resection, in particular pancreaticoduodenect-
omy (PD) or Whipple resection, is associated with significant
morbidity requiring detailed preoperative assessment and cau-
tious patient selection in order to minimize complications [2].
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The use of prophylactic TIPS for resectional cancer surgery is
uncommon, with only a single report of utilization to achieve
a major pancreatic resection [3]. Subsequently, we report on a
patient undergoing portal decompression via TIPS prior to a
Whipple resection, a combination referred to as the ‘Glasgow
Tipple’.
CASE REPORT
A 49-year-old male with no alcohol history presented to
Glasgow Royal Infirmary with a 3-month history of right upper
quadrant pain, jaundice, fever and 15 kg weight loss. Abdom-
inal examination revealed hepatosplenomegaly, confirmed by
abdominal ultrasound along with intrahepatic biliary tree
dilatation. Liver function analysis revealed a mildly elevated
bilirubin of 2.05mg/dl. Computed tomography (CT) imaging
demonstrated abrupt distal common bile duct (CBD) narrowing
yet normal pancreatic duct. Notably, significant portal hyper-
tension was evident with large para-esophageal varices and
splenomegaly (Fig. 1a). With no obvious risk factors for chronic
liver disease apart from obesity, alcoholic steatohepatitis was
suspected. While magnetic resonance cholangiopancreatogra-
phy was planned, cholangitis developed, prompting an ERCP,
which revealed Grade B esophageal varices, an edematous
ampulla (Fig. 1b) and a distal CBD filling defect, which was
biopsied, with biliary drainage achieved using a plastic double
pigtail stent. Histopathological examination revealed high-
grade dysplasia within the bile duct adenoma. With potential
for malignant progression, surgical resection was considered;
however, comorbidity including obesity and sleep apnea com-
pounded by portosystemic hypertension created a manage-
ment dilemma.
Hepatic vein wedge pressure measured 30mmHg compared
to an arterial pressure of 12mmHg confirmed portal hyperten-
sion; however, a fibroscan revealed no evidence of cirrhosis.
Prophylactic β-blockers were commenced. Liver histology from a
percutaneous biopsy suggested congenital hepatic fibrosis (CHF)
as a potential underlying cause of portal hypertension (Fig. 1c).
Following intense multidisciplinary discussion, it was decided
that in the context of a relatively young, cardiovascularly fit
patient with non-cirrhotic liver disease, a TIPS procedure was
appropriate, with a view to reconsidering surgery. A literature
search failed to identify evidence to support a decision to adopt
a staged TIPS with PD for a high-grade dysplastic lesion.
Significant residual biliary dilatation remained, which
prompted placement of a 6-cm partially covered metal wall
stent with subsequent improved drainage. A Viatorr® stent
graft (10mm, Gore) was then placed between the middle hep-
atic vein and left portal vein. Pre-TIPS pressures measured as
19mmHg was reduced to 7mmHg postprocedure; unfortu-
nately, this initial TIPS failed requiring a second, successful
procedure (Fig. 2a).
Following further deliberation and no evidence of metastatic
disease on imaging, the patient proceeded to resection. While
fibroscan had suggested a normal liver, intraoperative fibrosis
was encountered. Although few high-pressure veins were
noted, the TIPS had achieved successful portal decompression
enabling PD.
(a) (b) (c)
Figure 1: (a) Preoperative CT scan revealed significant portal hypertension with large para-esophageal varices and splenomegaly. (b) ERCP image demonstrating the
ampullary adenoma. (c) Liver biopsy reveals features in keeping with CHF.
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Figure 2: (a) Successful TIPPS deployment following insertion of a partially covered metallic biliary stent enabled portal decompression and resection to be performed.
(b) Postoperative CT scan revealed failure of the TIPS (arrow) along with SMV thrombus resulting in significant venous congestion of the small bowel. (c) Histological
examination of the resected specimen revealed a small cholangiocarcinoma.
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The patient subsequently developed postoperative pancrea-
titis, complicated on postoperative day 4 by respiratory distress
requiring intensive care unit admission. CT imaging revealed
small fluid collections related to the pancreatic anastomosis,
which were not amenable to drainage. Strikingly, repeat CT
scan on postoperative day 6 demonstrated TIPS failure with
extension of thrombus into the superior mesenteric vein (SMV)
and significant small bowel venous congestion. Despite the
ominous appearance (Fig. 2b) conservative management with
broad-spectrum antibiotics, inotropic support and low molecu-
lar weight heparin resulted in gradual improvement with dis-
charge home achieved on day 28. Final pathology unexpectedly
revealed a 15-mm pT1pN0 distal cholangiocarcinoma with
clear resection margins (Fig. 2c), for which no adjuvant therapy
was required.
DISCUSSION
In the case presented above, portal hypertension potentially
related to CHF was managed by preoperative TIPS insertion
enabling curative PD for a cholangiocarcinoma. While the min-
imally invasive modality of a TIPS can reduce portal pressure in
patients with severe liver cirrhosis, PD in patients with portal
hypertension secondary to liver disease is traditionally contra-
indicated due to increased transfusion requirement and high
mortality rate [4]. Previous studies have reported improved out-
comes in patients undergoing TIPS placement prior to major
nonhepatic surgery with a decrease in portal pressure improv-
ing surgical outcome due to reduced perioperative bleeding and
ascites [5]. There were however no previous literature reports
of this staged approach being utilized to facilitate a pancreatic
resection. Once this strategy for mitigating risk had been cho-
sen a resolute approach was followed. While complications fol-
lowing such a high-risk PD were not unexpected, postoperative
TIPS failure with subsequent significant visceral venous con-
gestion was not predicted and generated a challenging post-
operative period for which a conservative strategy achieved a
favorable outcome.
Of further interest is the diagnosis of CHF, a portobiliary sys-
tem developmental disorder characterized histologically by
defective ductal plate remodeling, progressive portal tract fibro-
sis and macroscopic cystic intrahepatic bile duct dilatation [6].
Clinical features include hepatomegaly, well-preserved hepato-
cellular function, portal hypertension resulting in splenomeg-
aly, hypersplenism and gastro-esophageal varices [6, 7].
Furthermore, CHF is associated with ciliopathies (primary cilia
disorders) that can result in renal disease [7]. Relative preserva-
tion of hepatocellular function despite hepatic fibrosis was a
factor in the decision to undertake resection in the described
case. There have been four reported cases of intrahepatic and a
single extrahepatic cholangiocarcinoma occurring on the back-
ground of CHF, this patient being the second [6–9]. A potential
mechanism by which the CHF intrahepatic biliary system
undergoes malignant transformation may be the result of
abnormal cholangiocyte cilia function [10].
This case demonstrates that in carefully selected patients
with preserved liver function there may be a role for minimally
invasive portal decompression to facilitate pancreatic resection
for malignancy. While not without risk, our multidisciplinary
strategy enabled a potentially curative resection for a patient
for whom abdominal surgery would normally be contraindi-
cated. We believe that carefully selected patients with pancre-
atic disease may benefit from this two-step approach and
therefore assessment in further patient collectives are
warranted.
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